ANTHEM BIOSCIENCES LTD Share Price

₹ 854.45

+₹18.95 (2.27%)
1D
Last updated 03 Nov, 2026, 15:54 IST
NSE: ANTHEM
|
Pharmaceuticals

ANTHEM BIOSCIENCES LTD Share Price Today

As of 4 Nov 2026, ANTHEM BIOSCIENCES LTD share price is ₹854.45. The stock opened at ₹836.00, compared to its previous close of ₹835.50. During today's trading session, ANTHEM BIOSCIENCES LTD share price moved in the range of ₹831.60 to ₹860.00, with an average price of ₹845.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹579.15 and a high of ₹977.55.

Share price over the last 1 day rose from 834.30 to 858.85, ranging between 831.90 and 858.85.
₹831.60
2.27% up today
₹860.00
1D LOW
1D HIGH

ANTHEM BIOSCIENCES LTD Stock Insights

Latest Earning
Op Profit TrendUp by 25.48% YoY
Latest Earning
Net Profit TrendUp by 31.14% YoY
Latest Earning
Revenue TrendUp by 18.12% YoY
Stock Performance
OutperformingBeat Nifty by 6.75 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.03%
Shareholding Pattern
DIIDII increased stake by 22.29%
Shareholding Pattern
FIIFII increased stake by 47.22%
ANTHEM BIOSCIENCES LTD stock performance
Open₹836.00
High₹860.00
Low₹831.60
Prev. close₹835.50
ANTHEM BIOSCIENCES LTD trading activity
Volume3,10,095
Average traded price₹847.79
Last traded time03:54:58 03 Nov
Last traded quantity2
Circuit
L
H
₹668.40
₹1,002.60
52-week
L
H
₹579.15
₹977.55
Mkt Cap Cr
47,351.41
P/E
82.25
P/B
15.56
ROA
16.8%
ROE
19.45%
ROCE
26.7%
Quick Ratio
5.15
EV/EBITDA
50.16

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Anthem Bioscienc has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Anthem Bioscienc appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Anthem Bioscienc earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,64,141.2490.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,300.8316.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ANTHEM BIOSCIENCES LTD Company Background

ISIN
INE0CZ201020
Sector Market Cap
₹ 47,351.41 Cr

Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.

ANTHEM BIOSCIENCES LTD Financial Highlights

  • Revenue: ANTHEM BIOSCIENCES LTD reported revenue of ₹2,280.11 crore in FY26 vs ₹1,930.28 crore in FY25. It showed an increase of 18.12% on a yearly basis.
  • Operating Profit: ANTHEM BIOSCIENCES LTD reported an operating profit of ₹824.24 crore in FY26 vs ₹656.87 crore in FY25. It showed an increase of 25.48% on a year-on-year basis.
  • Net Profit: ANTHEM BIOSCIENCES LTD reported a net profit of ₹591.79 crore in FY26 vs ₹451.26 crore in FY25. It showed an increase of 31.14% on a yearly basis.

ANTHEM BIOSCIENCES LTD Quarterly Result Highlights

  • ANTHEM BIOSCIENCES LTD reported revenue of ₹443.11 crore in Jun 2026, compared with ₹662.15 crore in Mar 2026, representing a decrease of 33.08% on a quarter-on-quarter (QoQ) basis.
  • ANTHEM BIOSCIENCES LTD reported an operating profit of ₹144.58 crore in Jun 2026, compared with ₹277.92 crore in Mar 2026, representing a decrease of 47.98% on a quarter-on-quarter (QoQ) basis.
  • ANTHEM BIOSCIENCES LTD reported a profit of ₹119.94 crore in Jun 2026, compared with ₹189.76 crore in Mar 2026, reflecting a decrease of 36.79% on a QoQ basis.
  • The earnings per share (EPS) of ANTHEM BIOSCIENCES LTD stood at ₹10.55 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
71.40%
FII
3.79%
Other DII
2.85%
Retail and other
12.70%
Mutual funds
9.25%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.36%
Mar 20261.28%
Jun 20262.58%
Sep 20263.79%

ANTHEM BIOSCIENCES LTD Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

ANTHEM BIOSCIENCES LTD Share Price History

ANTHEM BIOSCIENCES LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹836.00 / ₹854.45
+2.27%
02 Nov 26
₹825.00 / ₹835.50
+0.81%
30 Oct 26
₹827.00 / ₹828.80
-0.16%
29 Oct 26
₹831.20 / ₹830.15
-0.24%
Show more

ANTHEM BIOSCIENCES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,124.33₹1,844.55₹1,419.37₹1,056.92
Other Income₹155.78₹85.73₹63.70₹77.07
Total Revenue₹2,280.12₹1,930.29₹1,483.07₹1,133.99
Total Expenses₹1,431.49₹1,273.42₹1,005.75₹698.50
Profit Before Tax₹824.24₹656.87₹477.32₹497.30
Tax₹232.45₹205.61₹110.01₹112.11
Profit After Tax₹591.79₹451.26₹367.31₹385.19
EPS - Basic₹10.55₹8.07₹6.48₹6.75
EPS - Diluted₹10.43₹8.04₹6.48₹6.75

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹824.24₹656.87₹477.32₹497.30
Income before WC changes₹909.07₹730.24₹522.15₹524.62
Change in Assets₹138.30-₹324.97-₹338.56-₹36.41
Change in Liabilities₹1.12₹24.28₹76.56-₹67.22
Change in WC₹139.42-₹300.69-₹262.00-₹103.63
Cash flow from Operations₹844.49₹270.55₹140.15₹305.99
Cash flow from Investing-₹701.62-₹146.56-₹221.46-₹376.02
Cash flow from Financing-₹40.00-₹135.65-₹77.18₹63.97
Total Cash Flow₹102.87-₹11.66-₹158.49-₹6.06
Cash (Start of the year)₹172.28₹184.36₹342.85₹348.90
Cash (End of the year)₹274.88₹172.28₹184.36₹342.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,626.15₹1,319.41₹916.56₹691.29
Current Assets₹1,803.15₹1,488.17₹1,481.56₹1,323.17
Total Assets₹3,429.29₹2,807.58₹2,398.11₹2,014.46
Current Liabilities₹325.71₹326.23₹338.63₹163.87
Net Current Asset₹1,477.43₹1,161.94₹1,142.93₹1,159.30
Non-Current Liabilities₹61.06₹71.49₹134.83₹109.92
Equity Capital₹3,042.52₹2,409.87₹1,924.65₹1,740.67
Total Equity & Liabilities₹3,429.29₹2,807.58₹2,398.11₹2,014.46

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,089.31₹1,840.65₹1,417.54₹1,056.92
Other Income₹182.08₹109.44₹70.52₹77.37
Total Revenue₹2,271.39₹1,950.09₹1,488.06₹1,134.30
Total Expenses₹1,344.30₹1,238.67₹1,003.29₹698.32
Profit Before Tax₹903.07₹711.42₹484.77₹497.78
Tax₹232.51₹205.24₹109.99₹112.11
Profit After Tax₹670.56₹506.19₹374.78₹385.67
EPS - Basic₹11.95₹9.05₹6.61₹6.76
EPS - Diluted₹11.82₹9.01₹6.61₹6.76

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹903.07₹711.42₹484.77₹497.78
Income before WC changes₹924.93₹748.01₹521.94₹524.69
Change in Assets₹178.37-₹295.21-₹308.98-₹12.39
Change in Liabilities-₹9.88₹6.65₹71.44-₹78.32
Change in WC₹168.49-₹288.56-₹237.54-₹90.71
Cash flow from Operations₹889.42₹300.46₹164.41₹318.98
Cash flow from Investing-₹742.00-₹249.17-₹191.76-₹377.91
Cash flow from Financing-₹43.55-₹68.47-₹131.59₹52.85
Total Cash Flow₹103.87-₹17.18-₹158.95-₹6.07
Cash (Start of the year)₹166.25₹183.85₹342.79₹348.87
Cash (End of the year)₹269.85₹166.25₹183.85₹342.79

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,842.44₹1,420.04₹878.74₹673.39
Current Assets₹1,688.40₹1,415.52₹1,445.49₹1,319.62
Total Assets₹3,530.85₹2,835.56₹2,324.23₹1,993.02
Current Liabilities₹285.47₹291.17₹302.26₹152.61
Net Current Asset₹1,402.94₹1,124.35₹1,143.23₹1,167.01
Non-Current Liabilities₹60.68₹71.18₹88.89₹98.79
Equity Capital₹3,184.70₹2,473.21₹1,933.07₹1,741.62
Total Equity & Liabilities₹3,530.85₹2,835.56₹2,324.23₹1,993.02
* All values are in INR Crore
ANTHEM BIOSCIENCES LTD market depth
Bid quantityBid priceAsk priceAsk quantity
57854.4500
0000
0000
0000
0000
Total bid quantity57
Total ask quantity0
ANTHEM BIOSCIENCES LTD technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
45.42
Neutral
ATR (14)
24.27
Neutral
STOCH(9,6)
83.17
Bearish
STOCH RSI (14)
94.76
Bearish
ADX(9)
24.97
Bearish
UO(9)
60.32
Neutral
ROC(12)
-1.45
Bearish
WillR(14)
-44.87
Neutral
Period
Simple value
Exponential vaue
5D
836.21
838.57
10D
825.95
835.27
20D
842.3
842.54
50D
880.44
854.19
100D
839.38
837.03
Volume trend — traded volume by day
3 Nov3L
2 Nov2L
30 Oct2L
29 Oct2L
28 Oct0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ANTHEM BIOSCIENCES LTD
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in ANTHEM BIOSCIENCES LTD

Fund name
AUM
quant Healthcare Fund
9.26%
Quant Mid Cap Fund
4.85%
HDFC Pharma and Healthcare Fund
4.46%

ANTHEM BIOSCIENCES LTD Returns Calculator

Ex-date: 25 Jun 2026

ANTHEM BIOSCIENCES LTD Latest News

2 months ago
Laurus Labs to TVS Motor: 6 stocks that hit all-time highs on Wednesday; check full list
4 months ago
Anthem Biosciences sees 1.7 crore shares changing hands as Societe Generale, Prudential, among others, buy 3% stake
4 months ago
New India Assurance, Star Health, CDSL surge amid spike in trading activity; check full list
Showing news item 1 of 3

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

ANTHEM BIOSCIENCES LTD Share Price FAQs

Please be aware that ANTHEM BIOSCIENCES LTD stock prices are subject to continuous fluctuations due to various factors.